Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure

ClinicalTrials.gov ID: NCT00662610

Public ClinicalTrials.gov record NCT00662610. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 3:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Week, Phase 1, Multicenter, Double-Blind, Randomized, Dose Ranging, Forced Titration, Naproxen-Controlled, Parallel-Group, Pharmacodynamic Study, to Assess the Effects Different Doses of Naproxcinod and Naproxen on Arterial Blood Pressure as Measured by Ambulatory Blood Pressure Monitoring in Osteoarthritis Patients With Controlled Essential Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To assess the effect of naproxcinod vs. naproxen on arterial blood pressure patients with osteoarthritis and controlled essential hypertension

Study identification

NCT ID
NCT00662610
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
NicOx
Industry
Enrollment
120 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2008 (Type not available)
Primary completion
Aug 2008 (Actual)
Completion
Nov 2008 (Actual)
Last update posted
Jun 17, 2011

2008

United States locations

U.S. sites
29
U.S. states
21
U.S. cities
29
Facility City State ZIP Site status
Not listed Mobile Alabama — —
Not listed Tempe Arizona — —
Not listed Tucson Arizona — —
Not listed Beverly Hills California — —
Not listed Buena Park California — —
Not listed Colorado Springs Colorado — —
Not listed Boynton Beach Florida — —
Not listed Stockbridge Georgia — —
Not listed Boise Idaho — —
Not listed Chicago Illinois — —
Not listed Evansville Indiana — —
Not listed Newburgh Indiana — —
Not listed Terre Haute Indiana — —
Not listed Louisville Kentucky — —
Not listed New Orleans Louisiana — —
Not listed Billings Montana — —
Not listed Las Vegas Nevada — —
Not listed Edison New Jersey — —
Not listed Binghamton New York — —
Not listed Johnson City New York — —
Not listed Winston-Salem North Carolina — —
Not listed Cleveland Ohio — —
Not listed Duncansville Pennsylvania — —
Not listed Philadelphia Pennsylvania — —
Not listed Clarksville Tennessee — —
Not listed Austin Texas — —
Not listed Dallas Texas — —
Not listed Houston Texas — —
Not listed Norfolk Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00662610, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 17, 2011 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00662610 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →